[Retracted] Effects of DNA Immunoadsorption Combined with Medication on Immune Function and Renal Function in Patients with Systemic Lupus Erythematosus

Table 1

Comparison of general baseline information between the two groups.

	Control group (n = 42)	Observation group (n = 42)	x^2 /t
Gender (n (%))			0.060	0.806
Male	11	12
Woman	30	29
Mean age (years, x ± s)	33.95 ± 4.29	34.16 ± 4.07	0.230	0.819
Mean course of disease (years, x ± s)	2.16 ± 0.67	2.14 ± 0.64	0.140	0.889
SLEDAI score (score, x ± s)	22.07 ± 0.94	21.92 ± 0.87	0.759	0.450
Organ involvement (n (%))			0.135	0.987
Central nervous system	29	30
Heart	27	28
Lungs	21	19
Kidney	41	41
White blood cells (×10^9/L, x ± s)	5.35 ± 1.14	5.28 ± 1.37	0.255	0.799
Hemoglobin (g/l, x ± s)	96.84 ± 12.53	95.71 ± 10.96	0.051	0.960
Platelets (×10^9/L, x ± s)	216.74 ± 41.27	224.89 ± 42.73	0.889	0.377